Operating Lease, Right-of-Use Asset of Orchestra BioMed Holdings, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Orchestra BioMed Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • Orchestra BioMed Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,496,000, a 29% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Orchestra BioMed Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,496,000 -$607,000 -29% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 $1,653,000 -$61,000 -3.6% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,806,000 +$475,000 +36% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,956,000 +$455,000 +30% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $2,103,000 +$548,000 +35% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 $1,714,000 $0 0% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,331,000 -$543,000 -29% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,501,000 -$531,000 -26% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,555,000 -$632,000 -29% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,714,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,874,000 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,032,000 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $2,187,000 31 Dec 2022 10-K 27 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.